Net Income

Singapore's HomesToLife nearly doubles its net profit, fueled by a key acquisition and strong exports, defying global market headwinds that have hit rivals.

A new partnership aims to secure the growing army of non-human AI agents, promising rapid, secure deployment. But can it solve AI's identity crisis?

With over AUD$1M in sales from its first MDMA batch, Cortexa is validating Australia's pioneering move to legalize psychedelic-assisted therapy.

Facing financial pressure, Sleep Number launches its biggest product overhaul in a decade, hoping simpler choices and new tech can win back customers.

Niche's 2026 rankings reveal a major shift: Americans are choosing smaller, walkable communities that blend urban access with neighborhood charm.

Sydnexis's eye drop trial shows high efficacy in children 3-12, positioning it as a potential first-of-its-kind FDA-approved drug for myopia.

Tempest Therapeutics raises up to $6M in a critical financing deal to advance its CAR-T pipeline, balancing promising clinical data with financial pressures.

The bioconjugate CRDMO reports record profits and a $1.49B backlog, fueled by tech innovation, strategic acquisitions, and global expansion.

Nearly 200 Michigan lottery ticket workers secured record raises and benefits, signaling a major power shift in the national printing industry.

Lifecore Biomedical secures its third major manufacturing deal in five months, signaling a strategic shift that could reshape the aesthetics supply chain.

A new report shows a humorous "Potty Training for Grown-Ups" campaign is successfully curbing costly sewer clogs caused by non-flushable wipes.

With key trial enrollment complete, Pyxis Oncology refines its cancer drug MICVO for safety and prepares for pivotal data under a new, seasoned CEO.

The Texas fuel supplier is preparing a Nasdaq/NYSE move, banking on high energy prices from the Iran War to bolster its financials for the ambitious jump.

The European threat management firm is rapidly expanding in North America, leveraging a massive open-source community and a shift to proactive defense.

The L.A.-based bank extends its $300M stock repurchase program and will redeem $385M in notes, a move analysts see as a confident financial play.

Facing financial headwinds, Cyber Enviro-Tech signs a major deal to bring compressed air power to emerging markets. But can the technology and the company deliver?

Autonomous driving firm WeRide posts record 2025 revenue and narrows losses, fueled by aggressive international expansion and key driverless permits.

With major expansions in the US and Europe, Cambrex aims to lead the high-stakes race for specialized API production, targeting next-generation therapies.

A major labor dispute at the world's top drug manufacturer threatens global supply chains, with a union pointing to deep-seated governance issues at Samsung.

T1 Energy's upcoming results are the first major test of its pivot to U.S. solar manufacturing. Can it deliver on its high-stakes bet?